Non-Viral Gene Delivery to Hepatocellular Carcinoma via Intra-Arterial Injection

PURPOSE: Hepatocellular carcinoma (HCC) has limited treatment options, and modest survival after systemic chemotherapy or procedures such as transarterial chemoembolization (TACE). There is therefore a need to develop targeted therapies to address HCC. Gene therapies hold immense promise in treating...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaughan, Hannah J, Zamboni, Camila G, Luly, Kathryn M, Li, Ling, Gabrielson, Kathleen L, Hassan, Laboni F, Radant, Nicholas P, Bhardwaj, Pranshu, Selaru, Florin M, Pomper, Martin G, Green, Jordan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184850/
https://www.ncbi.nlm.nih.gov/pubmed/37197026
http://dx.doi.org/10.2147/IJN.S390384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184850/
https://www.ncbi.nlm.nih.gov/pubmed/37197026
http://dx.doi.org/10.2147/IJN.S390384

Ejemplares similares